MENTAL ILLNESS

Clinical trials for MENTAL ILLNESS explained in plain language.

Never miss a new study

Get alerted when new MENTAL ILLNESS trials appear

Sign up with your email to follow new studies for MENTAL ILLNESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 4 Completed 7 Terminated 1

New PTSD drug HB-1 heads to phase 2 trial

Symptom relief Not yet recruiting

This study tests whether HB-1 can safely reduce PTSD symptoms compared to a placebo. It involves 200 adults aged 18 to 65 with PTSD. Participants take HB-1 or placebo for 12 weeks, and doctors measure symptom changes using a standard PTSD scale.

Matched conditions: MENTAL ILLNESS

Phase: PHASE2 • Sponsor: HB BioTech, LLC • Aim: Symptom relief

Last updated May 17, 2026 03:41 UTC

MENTAL ILLNESS

Get alerted when new MENTAL ILLNESS trials appear

New PTSD drug HB-1 heads to phase 2 trial